Becton Dickinson (BDX): analysis and statistics
Return, volatility, Sharpe ratio and risk for Becton Dickinson, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $165.51 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | -7.14% |
| Total return over period | -19.83% |
| Annualized volatility | 25.23% |
| Sharpe ratio | -0.43 |
| Sortino ratio | -0.56 |
| Max drawdown | -39.86% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.53% |
| Correlation with the S&P 500 | 0.26 |
| Period range | $125.97 – $209.45 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Becton Dickinson (BDX) has posted an annualized return of -7.14% with annual volatility of 25.23%, a negative Sharpe ratio: over this period it did not beat the risk-free Treasury rate. Its worst stretch (max drawdown from a peak) was -39.86%. Its correlation with the S&P 500 is 0.26, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how BDX would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with BDX →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio